Blogs
Beyond the Scale — GLP-1s, Inflammation, and Metabolic Health
GLP-1 therapies don’t just help you lose weight—they improve inflammation, liver health, and insulin resistance. Learn how SLM+ supports deeper metabolic outcomes.
Read More
The Plateau Problem - Why GLP-1 Therapies Stop Working (and What To Do About It)
GLP-1s like Ozempic and Mounjaro work—until they don’t. Learn why patients plateau and how SLM+, amylin, and hormone cycling can help restore progress.
Read More
GLP-1, GIP, Amylin & Glucagon — What Really Drives Results?
GLP-1 therapies are powerful—but they aren’t the full picture. Learn how GIP, amylin, and glucagon work together and how SLM+ helps support multi-hormone weight loss.
Read More
What Comes After GLP-1s? The Future of Obesity & Metabolic Therapy
GLP-1s changed everything—but they’re just the beginning. Discover what’s next in obesity care: Retatrutide, CagriSema, oral therapies, nutraceuticals, and precision protocols.
Read More
Advanced GLP-1 Combination Protocols — Custom Strategies for Real-World Results
GLP-1s like semaglutide work—but they don’t work for everyone. Learn how providers are customizing protocols with pramlintide, SLM+, and new strategies for real-world results.
Read More
The Amylin Opportunity — Why GLP-1s Alone May Not Be Enough
GLP-1s like Ozempic® and Mounjaro® have transformed weight loss—but they may not be enough. Learn why amylin matters and how combination therapies could enhance results.
Read More